Echocardiography in Heart Failure Diagnosis and Management

Essential Parameters for Heart Failure Diagnosis

The European Society of Cardiology recommends that two-dimensional echocardiography with Doppler be performed during initial evaluation to assess left ventricular ejection fraction (LVEF), LV size, wall thickness, valve function, diastolic parameters, and right ventricular function 1, 2
LVEF measurement is mandatory to classify heart failure type: HFrEF (LVEF <40%), HFmrEF (LVEF 40-49%), or HFpEF (LVEF ≥50%) 3, 4
LV end-diastolic and end-systolic volumes should be measured, preferably using 3D echocardiography when available for greater accuracy 3, 4
LV wall thickness assessment identifies hypertrophy, which may indicate hypertensive heart disease, hypertrophic cardiomyopathy, or infiltrative disease 1, 2
Regional wall motion abnormalities suggest ischemic etiology and help identify infarct-related territories 5, 6
LV global longitudinal strain (LVGLS) should be measured, with values less negative than -18% indicating abnormal longitudinal function even when LVEF appears preserved 3, 4
LVGLS has demonstrated prognostic value in both HFrEF and HFpEF and can detect subclinical dysfunction 3, 4
E/e' ratio ≥14 indicates elevated LV filling pressures 3, 4
Average e' velocity <9 cm/s suggests impaired myocardial relaxation 3, 4
LA volume index reflects chronic diastolic burden and has prognostic significance 3

Comprehensive valve evaluation determines primary versus secondary etiology: mitral regurgitation severity and mechanism guides treatment decisions 3, 4
Aortic stenosis assessment (valve area, gradients) identifies obstruction contributing to heart failure 5, 6
Tricuspid regurgitation often develops secondary to RV dysfunction and pulmonary hypertension 3, 4
RV fractional area change quantifies RV systolic function 3, 4
RV free-wall longitudinal strain provides additional functional assessment 3, 4
Systolic pulmonary artery pressure (sPAP) estimation using tricuspid regurgitation velocity 3, 4
IVC diameter and respiratory collapse determine RA pressure: IVC >2.1 cm with <50% collapse suggests RA pressure of 15 mmHg; IVC <2.1 cm with >50% collapse suggests 3 mmHg 3, 4

Ischemic wall motion abnormalities with viable myocardium on stress or contrast echocardiography indicate potential benefit from revascularization 5, 6
Severe valvular disease may require surgical or percutaneous intervention 3, 4
Elevated filling pressures (E/e' ≥14) guide diuretic therapy intensity 3, 4
Changes in LVEF, LV volumes, and LVGLS indicate therapeutic efficacy 3, 4
Worsening diastolic parameters or increasing pulmonary pressures signal clinical deterioration 3, 4
LV mass regression with treatment correlates with improved outcomes 5, 6